74 related articles for article (PubMed ID: 1135891)
21. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
22. ABVD chemotherapy of Hodgkin's disease.
Molnár Z; Schneider T; Várady E; Fleischmann T
Neoplasma; 1997; 44(4):263-5. PubMed ID: 9473781
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of BOVAPEC in the primary treatment of Hodgkin's lymphoma intermediate stages].
Raida L; Papajík T; Indrák K; Herman M; Paucek B; Zapletalová J
Vnitr Lek; 2007 Jan; 53(1):31-7. PubMed ID: 17472013
[TBL] [Abstract][Full Text] [Related]
25. [Combination chemotherapy in Hodgkin's disease].
Andersson T; Landberg T; Möller TR
Lakartidningen; 1974 May; 71(18):1844-6. PubMed ID: 4597780
[No Abstract] [Full Text] [Related]
26. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
Huisman RM; de Jong PE; de Zeeuw D; van Imhoff GW; van der Hem GK
Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
[TBL] [Abstract][Full Text] [Related]
27. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
28. [Drug therapy of lymphogranulomatosis].
Lorie IuI; Kondrat'eva AP; Kaverzneva MM
Med Radiol (Mosk); 1973 May; 18(5):32-7. PubMed ID: 4769901
[No Abstract] [Full Text] [Related]
29. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of advanced-stage Hodgkin's lymphoma patients treated with either COPP or ABVD drug combinations].
Molnár Z; Fleischmann T
Orv Hetil; 1992 Jun; 133(25):1561-3. PubMed ID: 1383902
[TBL] [Abstract][Full Text] [Related]
32. [Combination chemotherapy of advanced Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Mizunuma N; Ogawa M; Kuraishi Y; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Itami S
Rinsho Ketsueki; 1991 Nov; 32(11):1410-5. PubMed ID: 1758048
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of local Hodgkin's disease with massive mediastinal involvement].
Kondrat'eva NE; Demina EA; Nivinskaia MM; Iur'eva TV; Unukova EN; Paches LR; Pirogova NA
Ter Arkh; 2000; 72(8):45-9. PubMed ID: 11019428
[TBL] [Abstract][Full Text] [Related]
34. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
35. Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy.
Tomandl J; Palyza V; Tallová J; Drbal J
J Exp Clin Cancer Res; 2004 Mar; 23(1):157-61. PubMed ID: 15149166
[TBL] [Abstract][Full Text] [Related]
36. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
37. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
38. Cyclophosphamide and vinblastine sulfate in Hodgkin's disease during pregnancy.
Lacher MJ; Geller W
JAMA; 1966 Feb; 195(6):486-8. PubMed ID: 5951840
[No Abstract] [Full Text] [Related]
39. [Urinary excretion of 5-hydroxyindoleacetic acid in patients treated for Hodgkin's disease].
Chocha A; Kuchciński R; Szklarska W; Urbaniak Z
Wiad Lek; 1976 Oct; 29(20):1795-7. PubMed ID: 997501
[No Abstract] [Full Text] [Related]
40. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice.
Tyburski JB; Patterson AD; Krausz KW; Slavík J; Fornace AJ; Gonzalez FJ; Idle JR
Radiat Res; 2009 Jul; 172(1):42-57. PubMed ID: 19580506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
